Insiders · FULC

Bryan Stuart

Officer, Director at Fulcrum Therapeutics, Inc. (FULC)

Bryan Stuart has filed 3 insider reports with the SEC since January 2021, as officer and director at Fulcrum Therapeutics, Inc. (FULC). The latest filing, on January 21, 2022, reports grant or award at Fulcrum Therapeutics, Inc. (FULC).

Filings
3
Companies
1
Bought on market
None
Sold on market
None

Companies where Bryan Stuart is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Fulcrum Therapeutics, Inc. logo
FULC
Fulcrum Therapeutics, Inc.
Officer, Director$3.75Jan 21, 2022

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare Bryan Stuart with

Other insiders at the same companies

Questions about Bryan Stuart

What is Bryan Stuart's role at Fulcrum Therapeutics, Inc.?
Bryan Stuart reports to the SEC as officer and director at Fulcrum Therapeutics, Inc. (FULC), according to the latest filing on January 21, 2022.
Has Bryan Stuart bought or sold stock recently?
No open-market purchases or sales by Bryan Stuart are on file. The filings report grant or award.
How do I get alerts when Bryan Stuart files?
Follow Bryan Stuart on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Bryan Stuart (SEC CIK 0001619846). Totals count each trade once, skipping amendments whose original is on file, from Jan 27, 2021 on. View on SEC EDGAR